Ze Lin Sheng
Fortuna: 737 M $ al 31/05/2026
Fortuna: 737 M $ al 31/05/2026
Ze Lin Sheng is the Chairman & General Manager of Suzhou Zelgen Biopharmaceuticals Co., Ltd., which he founded in 2009.
He holds a doctorate degree from the University of Miami, an MBA from China Europe International Business School, and a graduate degree from Zhengzhou University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/01/2026 | 49.910.527 ( 18,85 % ) | 737 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD. | Director Ejecutivo | 18/03/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zhengzhou University
Zhengzhou University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes threespecific antibody medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.